Windtree Announces Plan for Cryptocurrency Treasury Policy

Core Viewpoint - Windtree Therapeutics, Inc. plans to implement a cryptocurrency policy to accept cryptocurrency as a payment option and hold it as an asset, aligning with digital commerce trends [1][2][3] Company Strategy - The company is focused on becoming a revenue-generating entity while advancing innovative therapies for critical conditions and diseases [4] - Windtree is in discussions with groups specializing in Bitcoin and other cryptocurrencies to develop a treasury strategy [3] Cryptocurrency Policy - The cryptocurrency policy aims to allow the company to accept cryptocurrency payments and hold them long-term as a strategic asset [2][3] - The Board of Directors supports the development of this cryptocurrency policy, which is expected to be completed soon [3] Product Portfolio - Windtree's product candidates include istaroxime, a Phase 2 candidate for acute heart failure, and preclinical SERCA2a activators and precision aPKCi inhibitors for oncology applications [4]